Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Net Income
(530.20) 711.50 321.10 686.50 572.60 116.60 37.80 (86.90) (145.30) (42.00)
Depreciation & Amortization
418.70 416.70 415.30 421.20 395.50 418.80 432.40 446.00 110.90 60.30
Non Cash Items (Other)
935.50 (334.80) 117.70 64.20 97.00 372.00 95.80 (60.40) (213.90) —
Accounts Receivable Change
13.60 45.90 77.00 (45.20) (111.80) (102.40) (68.90) (83.40) 14.10 (7.90)
Change in inventories
(109.40) (18.50) 30.30 (112.50) (129.80) (69.70) (84.10) (41.10) 19.70 (13.00)
Accounts Payable Change
42.40 59.60 (139.60) 15.60 64.90 110.60 (2.00) 34.20 31.80 —
Change in payables and accrued liability
(1.30) (1.60) 0.30 0.10 5.30 (29.70) (2.40) (2.40) 32.00 5.50
Change in other assets and liabilities
(145.50) (38.00) 47.90 (186.30) 59.90 113.60 (54.60) (5.50) 15.20 (9.90)
Operating Cash Flow
623.80 840.80 870.00 843.60 953.60 929.80 354.00 200.50 (167.50) 72.90
Capital expenditures
(128.80) (148.80) (146.40) (133.40) (111.10) (61.60) (51.60) (37.70) (25.20) —
Net Aquisitions
— 585.20 — (20.20) (4,014.10) — — — (6,660.70) —
Other investing activities
(1.70) 2.50 2.70 44.00 3.50 2.50 9.50 14.50 9.90 (23.10)
Investing cash flow
(130.50) 438.90 (143.70) (109.60) (4,121.70) (59.10) (42.10) (23.20) (6,676.00) (29.90)
Repayment/Issuance of Debt (Net)
(318.70) (1,341.80) (846.00) (619.80) 2,300.70 (422.70) (1,877.30) (149.80) 5,958.90 840.50
Equity Repurchase (Common, Net)
(80.70) (8.60) (13.70) (13.20) 941.20 — 4,235.60 — 3,049.00 —
Equity Repurchase (Preffered, Net)
— — — — — — (2,630.90) — — —
Dividends Paid (Total)
— — — (32.40) (64.60) (64.60) (31.30) — (1,701.90) (158.70)
Other financial activities
(10.00) 69.20 16.00 16.70 41.90 (295.60) (3.90) (20.50) (341.00) 95.50
Financing cash flow
(409.40) (1,281.20) (843.70) (648.70) 3,219.20 (782.90) (307.80) (170.30) 6,965.00 (43.50)
Exchange Rate Adjustment
19.70 (21.50) 8.20 (15.50) (13.20) 12.10 (2.50) (7.80) 1.00 —
Change in Cash
103.60 (23.00) (109.20) 69.80 37.90 99.90 1.60 (0.80) 122.50 (1.20)
Beginning Cash
264.70 287.70 396.90 327.10 289.20 189.30 187.70 188.50 66.00 —
Ending Cash
368.30 264.70 287.70 396.90 327.10 289.20 189.30 187.70 188.50 —
Stock Based Compensation
46.40 46.80 40.50 45.80 50.70 44.10 67.90 18.40 48.20 —
Dividends Paid (Common)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (1,701.90) —
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(200.20) 47.40 15.90 (328.30) (111.50) 22.40 (212.00) (98.20) 80.80 —
Dividends Paid (Preffered)
— 0.00 0.00 (32.40) (64.60) (64.60) (31.30) — — —
Issuance/Purchase of Shares
(80.70) (8.60) (13.70) (13.20) 941.20 — 1,604.70 — 3,049.00 —
Other line items
Revenue per Employee
0.49 0.50 0.48 0.52 0.55 0.52 0.50 0.49 0.00 0.00

Fold the line items

In millions of $ except per-share values · columns are period end dates